Home › Stocks › IOVA

Iovance Biotherapeutics, Inc. (IOVA): insider buying, hedge funds & Congress trades

Iovance Biotherapeutics, Inc. (IOVA): 3 insider purchases in the last two years.

Insider buying

FiledInsiderSharesPriceValueType
Jun 6, 2025Kirby Daniel Gordon
Officer
30,000$1.84$55.2Kno history
May 27, 2025Puri Raj K.
Officer
5,600$1.74$9.7Kno history
May 16, 2025Vogt Frederick G
Director, Officer
25,000$1.69$42.2Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for IOVA

Free account. Know when insiders, famous funds or Congress trade it.

Start free